CClinicalTrials.gg
RecruitingNCT06724666NEURO4CUpdated Apr 4, 2025

Transdiagnostic Internet-delivered Intervention for Adolescents With Anxiety and Depression

An interventional study of Transdiagnostic Internet-delivered intervention in Anxiety Disorders, Depressive Disorder and Social Anxiety Disorder, sponsored by Babes-Bolyai University. Recruiting at 2 sites in Romania. Open to participants aged 13 Years to 17 Years. Per ClinicalTrials.gov, last updated 2025-04-04.

Sponsored by Babes-Bolyai University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Primary completion was expected by Dec 2025, 9 months ago, but the record still lists the study as recruiting.
  • Started Apr 2025; still recruiting 1 year 6 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
198
Allocation
Randomized
Ages
13 Years to 17 Years
Sex
All
01

Study summary

The goal of this clinical trial is to test the efficacy of a transdiagnostic Internet-delivered interventions for Romanian adolescents with anxiety and/ or depression. The main questions it aims to answer are:

  • What is the clinical efficacy of the Internet-delivered intervention?
  • How accurate is the prediction model in predicting who will respond to treatment? Participants will undergo non-invasive fMRI to measure variability in brain signal as a proxy of the neural systems' adaptability before receiving the intervention, then they will be allocated either to the Internet-delivered intervention or control group.
Read the detailed description

To the best of investigators' knowledge, this is the first clinical trial conducted with adolescents diagnosed with anxiety/and or depressive disorders that tests the accuracy of a prediction model based on fMRI to investigate participants' response to a transdiagnostic Internet-delivered intervention.

02

Conditions studied

  • Anxiety Disorders
  • Depressive Disorder
  • Social Anxiety Disorder
  • Major Depressive Disorder
  • Dysthymia
  • Generalized Anxiety Disorder

Keywords

  • Internet-delivered intervention
  • transdiagnostic
  • adolescents
  • internalizing
  • anxiety
  • depression
03

In context

Depression

8,057 studies on the registry are indexed under Depression; 1,641 are open to participants now.

This study's planned enrollment of 198 is above the median of 84 across 6,720 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

Babes-Bolyai University is the lead sponsor of 48 studies on the registry; 12 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
13 Years to 17 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • elevated symptoms of anxiety or depression/ internalizing problems (T score> 60) at intake (based on Youth self-report completed by adolescents)
  • primary diagnosis of an anxiety/depressive disorder based on DSM-5 criteria according to ADIS-5-C/P interview
  • age 13-17
  • able to read and understand Romanian language
  • Currently unmedicated or on stable and adequate doses of medication for at least 6 weeks before treatment onset
  • Internet access

Exclusion criteria

Exclusion Criteria:

  • severe mental disorder (psychosis, severe depression, bipolar disorder, based on clinical interview)
  • any condition that interferes with the protocol implementation (e.g., physical illness or sensory impairment that interferes with behavioral tasks such as exposure, behavioral activation, unavailable for the next 3 months),
  • active suicidal ideation (assessed by child psychiatrist during clinical interview) in the last month
  • currently following CBT/ psychotherapy for anxiety/depression, in the last 6 months
  • fMRI incompatible (based on safety questionnaire)
  • Being diagnosed with an intellectual disability, pervasive developmental disorder, an alcohol and/or substance dependence disorder, reading disabilities (based on clinical interview).
  • Current treatment with benzodiazepines
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
198 participants (estimated)

Study arms

  • Experimental
    Transdiagnostic Internet-delivered intervention

    The intervention consists of 8 modules delivered over 8 weeks. It is based on Rational Emotive Behavioral Therapy (REBT).

    Behavioral: Transdiagnostic Internet-delivered intervention

  • No intervention
    Control group

    Participants in the control group are a delayed intervention group (waiting list control). They will access the intervention after 8 weeks.

Interventions

  • BehavioralTransdiagnostic Internet-delivered intervention

    The intervention consists of 8 modules based on Rational emotive therapy, delivered via 8 weeks.

06

What researchers measure

Primary outcomes

  1. Internalizing problems

    Change from baseline in internalizing problems. Revised Children's Anxiety and Depression Scale (RCADS) completed by adolescents.

    Time frame: baseline, after 8 weeks of intervention, 6 months follow-up

Secondary outcomes

  1. Clinical diagnosis

    Change in DSM-5 Anxiety and Depressive Disorder Diagnoses in Accordance with Anxiety Disorders Interview Schedule for the DSM-5, Child and Parent Versions (ADIS-5-C/P) Clinical Diagnosis

    Time frame: administered pre-baseline, post-baseline (after 8 week waitlist period), after 8 weeks of intervention

  2. Global functioning

    Children's Global Assessment Scale (C-GAS)

    Time frame: baseline, after 8 weeks of intervention, 6 months follow-up

  3. Severity

    Clinical Global Impression Scale - Severity

    Time frame: baseline, after 8 weeks of intervention, 6 months follow-up

  4. Improvement

    Clinical Global Impression Scale - Improvement

    Time frame: after 8 weeks of intervention, 6 months follow-up

  5. Comorbid problems

    Subscales of the Revised Children's Anxiety and Depression Scale (RCADS) completed by adolescents

    Time frame: baseline, after 8 weeks of intervention, 6 month follow-up

  6. Life satisfaction

    SWLS-C: Satisfaction with Life Scale for Children

    Time frame: baseline, after 8 weeks of intervention, 6 months follow-up

  7. Satisfaction with the Internet-delivered intervention

    Client Satisfaction Questionnaire (CSQ-8)

    Time frame: after 8 weeks of intervention

  8. Working alliance

    Working alliance scale for Internet interventions

    Time frame: after 8 weeks of intervention

  9. Automatic thoughts

    Automatic thoughts questionnaire

    Time frame: baseline, after 8 weeks of intervention, 6 month follow-up

  10. Credibility and expectations

    Credibility and expectations questionnaire

    Time frame: week 2

  11. Credibility and expectations based on primary outcome measure

    Credibility and expectations based on primary outcome scale

    Time frame: baseline

  12. Anxiety and depressive symptoms

    PHQ4

    Time frame: baseline, at each 2 weeks during treatment duration, after 8 weeks of intervention, 6 months follow-up

  13. Avoidance

    CAMS

    Time frame: baseline, after 8 weeks of intervention, 6 month follow-up

  14. Parental distress

    DASS-21

    Time frame: baseline

  15. Adolescent anxiety and depressive symptoms as reported by parents

    RCADS-47 parent report

    Time frame: baseline, after 8 weeks of intervention, 6 month follow-up

  16. Parental accommodations

    Family accommodation scale - parent report

    Time frame: baseline

07

Study locations

1 of 2 sites recruiting
  • Babes-Bolyai University
    Cluj-Napoca, 400015, Romania
    Not yet recruiting
  • Babeș-Bolyai University
    Cluj-Napoca, 400015, Romania
    Recruiting
08

References and documents

Individual participant data

Plan to share: Yes — Deidentified individual participant data will be will be shared after the publication of the results.

Supporting information: Study protocol, Sap, Icf, Analytic code

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 4, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06724666
Lead sponsor
Babes-Bolyai University
Responsible party
Costina-Ruxandra Poetar (Assistant professor, Babes-Bolyai University) — Principal investigator
First posted
Dec 9, 2024
Start date
Apr 1, 2025
Primary completion
Dec 31, 2025 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
Apr 4, 2025

Study contacts

Kristoffer Mansson, PhD
Contact
nils.mansson@ubbcluj.ro
+46705803267
Costina Poetar, PhD
study chair · Babeș-Bolyai University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion